Skip to main content
OliX Pharmaceuticals, Inc. logo

OliX Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · 226950 ISIN · KR7226950004 KO Manufacturing
Filings indexed 365 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 226950

About OliX Pharmaceuticals, Inc.

https://olixpharma.com

OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 92% confidence The document is titled “분기보고서” covering the period 2026-01-01 to 2026-03-31 and includes substantive financial data (e.g., revenue by segment, program descriptions, financial figures) typical of a full quarterly regulatory filing in Korea. This matches the definition of an Interim/Quarterly Report rather than a brief earnings release or an announcement. Therefore, it should be classified as IR. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 90% confidence The document is a ‘주식등의 대량보유상황보고서(약식)’ – a regulatory filing under Korea’s Capital Market Act reporting a large shareholding by the National Pension Service in 올릭스, including share counts and ownership percentages that cross the 5% threshold. This matches the definition of a Major Shareholding Notification (MRQ).
2026-04-01 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a summary of the regular shareholders’ meeting held on 2026-03-26, detailing approval of financial statements, dividend resolutions, director appointments, and vote counts/percentages for each agenda item. This is precisely the publication of shareholder vote results at an AGM, matching the definition of “Declaration of Voting Results & Voting Rights Announcements.”
2026-03-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 90% confidence The document is a regulatory filing to the Financial Services Commission/Korea Exchange notifying the grant of stock purchase options (주식매수선택권 부여). It details the number of options, exercise conditions, beneficiaries, and valuation assumptions. This constitutes a capital change announcement regarding new share issuance rights rather than a management change, earnings release, or full report publication. Therefore, it best fits the Share Issue/Capital Change category (SHA).
2026-03-26 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 90% confidence The document is a disclosure filed with the Financial Supervisory Commission/KRX detailing the appointment, dismissal, or mid‐term resignation of outside directors, including dates and biographical details of the new outside director. This clearly falls under announcements of changes in the company's board of directors, matching the Board/Management Information category.
2026-03-26 Korean
사업보고서 (2025.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for the 16th fiscal year (2025), covering company overview, history, capital structure, and detailed business operations. It is a formal, long-form regulatory filing submitted to the Financial Supervisory Service and Korea Exchange. Given its content, structure, and purpose as a primary annual financial and operational disclosure, it is classified as a 10-K (Annual Report). FY 2025
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.